Insider Selling: Ryan Specialty Holdings, Inc. (NYSE:RYAN) Director Sells 10,485 Shares of Stock

Ryan Specialty Holdings, Inc. (NYSE:RYAN) Director Nicholas Dominic Cortezi sold 10,485 shares of the business’s stock in a transaction that occurred on Thursday, January 23rd. The shares were sold at an average price of $65.12, for a total value of $682,783.20. Following the completion of the transaction, the director now directly owns 11,109 shares of the company’s stock, valued at $723,418.08. The trade was a 48.56 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website.

Nicholas Dominic Cortezi also recently made the following trade(s):

• On Tuesday, January 21st, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The shares were sold at an average price of $66.35, for a total transaction of $2,322,250.00.
• On Friday, January 17th, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The shares were sold at an average price of $67.15, for a total transaction of $2,350,250.00.
• On Wednesday, January 15th, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The stock was sold at an average price of $65.99, for a total transaction of $2,309,650.00.
• On Monday, January 13th, Nicholas Dominic Cortezi sold 29,466 shares of Ryan Specialty stock. The shares were sold at an average price of $65.06, for a total value of $1,917,057.96.
• On Friday, December 20th, Nicholas Dominic Cortezi sold 91 shares of Ryan Specialty stock. The stock was sold at an average price of $65.00, for a total value of $5,915.00.
• On Wednesday, December 18th, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The shares were sold at an average price of $65.17, for a total value of $2,280,950.00.
• On Monday, December 16th, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The stock was sold at an average price of $66.71, for a total value of $2,334,850.00.
• On Friday, December 13th, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The shares were sold at an average price of $67.39, for a total transaction of $2,358,650.00.

Ryan Specialty Trading Down 1.5 %

Shares of NYSE RYAN traded down $0.99 during trading on Friday, hitting $63.27. 1,379,301 shares of the company were exchanged, compared to its average volume of 1,031,793. The company has a fifty day moving average price of $67.49 and a 200-day moving average price of $66.10. The company has a debt-to-equity ratio of 2.40, a quick ratio of 1.01 and a current ratio of 1.01. The firm has a market capitalization of $16.57 billion, a PE ratio of 82.16, a P/E/G ratio of 1.14 and a beta of 0.72. Ryan Specialty Holdings, Inc. has a 12-month low of $42.21 and a 12-month high of $75.97.

Ryan Specialty (NYSE:RYAN) last issued its earnings results on Wednesday, October 30th. The company reported $0.41 EPS for the quarter, hitting analysts’ consensus estimates of $0.41. Ryan Specialty had a net margin of 10.31% and a return on equity of 47.90%. The company had revenue of $604.69 million for the quarter, compared to the consensus estimate of $602.04 million. During the same period in the previous year, the firm earned $0.32 earnings per share. Ryan Specialty’s quarterly revenue was up 20.5% compared to the same quarter last year. As a group, equities research analysts expect that Ryan Specialty Holdings, Inc. will post 1.82 EPS for the current year.

Ryan Specialty Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, November 26th. Investors of record on Tuesday, November 12th were issued a $0.11 dividend. This represents a $0.44 dividend on an annualized basis and a yield of 0.70%. The ex-dividend date of this dividend was Tuesday, November 12th. Ryan Specialty’s dividend payout ratio is presently 57.14%.

Analysts Set New Price Targets

Several research firms have issued reports on RYAN. Wells Fargo & Company decreased their price objective on shares of Ryan Specialty from $68.00 to $64.00 and set an “equal weight” rating on the stock in a report on Tuesday, January 14th. The Goldman Sachs Group lifted their price objective on Ryan Specialty from $64.00 to $72.00 and gave the stock a “neutral” rating in a report on Wednesday, October 9th. Bank of America increased their target price on Ryan Specialty from $75.00 to $84.00 and gave the company a “buy” rating in a report on Thursday, October 10th. Morgan Stanley started coverage on Ryan Specialty in a research note on Thursday, December 5th. They issued an “overweight” rating and a $90.00 price target on the stock. Finally, Barclays increased their price objective on Ryan Specialty from $76.00 to $88.00 and gave the company an “overweight” rating in a research note on Thursday, November 21st. One research analyst has rated the stock with a sell rating, five have given a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $74.40.

Institutional Investors Weigh In On Ryan Specialty

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Vanguard Personalized Indexing Management LLC acquired a new position in shares of Ryan Specialty in the 2nd quarter valued at $248,000. Thrivent Financial for Lutherans lifted its position in Ryan Specialty by 519.6% in the second quarter. Thrivent Financial for Lutherans now owns 28,803 shares of the company’s stock valued at $1,668,000 after buying an additional 24,154 shares during the last quarter. ProShare Advisors LLC purchased a new position in Ryan Specialty during the second quarter worth about $280,000. Xponance Inc. increased its position in shares of Ryan Specialty by 67.2% during the second quarter. Xponance Inc. now owns 20,686 shares of the company’s stock valued at $1,198,000 after acquiring an additional 8,312 shares during the last quarter. Finally, AQR Capital Management LLC acquired a new stake in shares of Ryan Specialty during the second quarter valued at about $261,000. Institutional investors and hedge funds own 84.82% of the company’s stock.

About Ryan Specialty

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.